Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy.

Biomedical optics express

Lee SY, Lloyd WR, Chandra M, Wilson RH, McKenna B, Simeone D, Scheiman J, Mycek MA.
PMID: 24409383
Biomed Opt Express. 2013 Nov 14;4(12):2828-34. doi: 10.1364/BOE.4.002828. eCollection 2013.

In a pilot study, multimodal optical spectroscopy coupled with quantitative tissue-optics models distinguished intraductal papillary mucinous neoplasm (IPMN), a common precursor to pancreatic cancer, from normal tissues in freshly excised human pancreas. A photon-tissue interaction (PTI) model extracted parameters...

Cite
Lee SY, Lloyd WR, Chandra M, et al. Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy. Biomed Opt Express. 2013;4(12):2828-34doi: 10.1364/BOE.4.002828.
Lee, S. Y., Lloyd, W. R., Chandra, M., Wilson, R. H., McKenna, B., Simeone, D., Scheiman, J., & Mycek, M. A. (2013). Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy. Biomedical optics express, 4(12), 2828-34. https://doi.org/10.1364/BOE.4.002828
Lee, Seung Yup, et al. "Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy." Biomedical optics express vol. 4,12 (2013): 2828-34. doi: https://doi.org/10.1364/BOE.4.002828
Lee SY, Lloyd WR, Chandra M, Wilson RH, McKenna B, Simeone D, Scheiman J, Mycek MA. Characterizing human pancreatic cancer precursor using quantitative tissue optical spectroscopy. Biomed Opt Express. 2013 Nov 14;4(12):2828-34. doi: 10.1364/BOE.4.002828. eCollection 2013. PMID: 24409383; PMCID: PMC3862164.
Copy Download .nbib Format: NLM
Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Verleger K, Schoeman O, Schmidt R, Wilke T, Heeg B.
PMID: 27201169
Value Health. 2014 Nov;17(7):A438. doi: 10.1016/j.jval.2014.08.1141. Epub 2014 Oct 26.

No abstract available.

Cite
Verleger K, Schoeman O, Schmidt R, et al. Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis. Value Health. 2014;17(7):A438doi: 10.1016/j.jval.2014.08.1141.
Verleger, K., Schoeman, O., Schmidt, R., Wilke, T., & Heeg, B. (2014). Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A438. https://doi.org/10.1016/j.jval.2014.08.1141
Verleger, K, et al. "Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A438. doi: https://doi.org/10.1016/j.jval.2014.08.1141
Verleger K, Schoeman O, Schmidt R, Wilke T, Heeg B. Predictors of German Amnog Decisions and GKV Rebate Negotiations: A Database Analysis. Value Health. 2014 Nov;17(7):A438. doi: 10.1016/j.jval.2014.08.1141. Epub 2014 Oct 26. PMID: 27201169.
Copy Download .nbib Format: NLM
Tuberculosis care--what does it cost the patient?.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Schoeman JH, Dick J.
PMID: 9608313
S Afr Med J. 1998 Mar;88(3):394, 396.

No abstract available.

Cite
Schoeman JH, Dick J. Tuberculosis care--what does it cost the patient?. S Afr Med J. 1998;88(3):394, 396
Schoeman, J. H., & Dick, J. (1998). Tuberculosis care--what does it cost the patient?. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 88(3), 394, 396.
Schoeman, and Dick. "Tuberculosis care--what does it cost the patient?." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde vol. 88,3 (1998): 394, 396.
Schoeman JH, Dick J. Tuberculosis care--what does it cost the patient?. S Afr Med J. 1998 Mar;88(3):394, 396. PMID: 9608313.
Copy Download .nbib Format: NLM
Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study.

International journal of MS care

Sullivan AB, Scheman J, Lopresti A, Prayor-Patterson H.
PMID: 24453754
Int J MS Care. 2012;14(4):216-20. doi: 10.7224/1537-2073-14.4.216.

The objective of this study was to examine the efficacy of an interdisciplinary pain rehabilitation program in a multiple sclerosis (MS) population by evaluating changes in mood, pain, and functioning. This descriptive study examined 20 patients with chronic pain...

Cite
Sullivan AB, Scheman J, Lopresti A, et al. Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study. Int J MS Care. 2012;14(4):216-20doi: 10.7224/1537-2073-14.4.216.
Sullivan, A. B., Scheman, J., Lopresti, A., & Prayor-Patterson, H. (2012). Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study. International journal of MS care, 14(4), 216-20. https://doi.org/10.7224/1537-2073-14.4.216
Sullivan, Amy Burleson, et al. "Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study." International journal of MS care vol. 14,4 (2012): 216-20. doi: https://doi.org/10.7224/1537-2073-14.4.216
Sullivan AB, Scheman J, Lopresti A, Prayor-Patterson H. Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study. Int J MS Care. 2012;14(4):216-20. doi: 10.7224/1537-2073-14.4.216. PMID: 24453754; PMCID: PMC3882988.
Copy Download .nbib Format: NLM
Methods for the extraction and RNA profiling of exosomes.

World journal of methodology

Zeringer E, Li M, Barta T, Schageman J, Pedersen KW, Neurauter A, Magdaleno S, Setterquist R, Vlassov AV.
PMID: 25237619
World J Methodol. 2013 Mar 26;3(1):11-8. doi: 10.5662/wjm.v3.i1.11. eCollection 2013 Mar 26.

AIM: To develop protocols for isolation of exosomes and characterization of their RNA content.METHODS: Exosomes were extracted from HeLa cell culture media and human blood serum using the Total exosome isolation (from cell culture media) reagent, and Total exosome...

Cite
Zeringer E, Li M, Barta T, et al. Methods for the extraction and RNA profiling of exosomes. World J Methodol. 2013;3(1):11-8doi: 10.5662/wjm.v3.i1.11.
Zeringer, E., Li, M., Barta, T., Schageman, J., Pedersen, K. W., Neurauter, A., Magdaleno, S., Setterquist, R., & Vlassov, A. V. (2013). Methods for the extraction and RNA profiling of exosomes. World journal of methodology, 3(1), 11-8. https://doi.org/10.5662/wjm.v3.i1.11
Zeringer, Emily, et al. "Methods for the extraction and RNA profiling of exosomes." World journal of methodology vol. 3,1 (2013): 11-8. doi: https://doi.org/10.5662/wjm.v3.i1.11
Zeringer E, Li M, Barta T, Schageman J, Pedersen KW, Neurauter A, Magdaleno S, Setterquist R, Vlassov AV. Methods for the extraction and RNA profiling of exosomes. World J Methodol. 2013 Mar 26;3(1):11-8. doi: 10.5662/wjm.v3.i1.11. eCollection 2013 Mar 26. PMID: 25237619; PMCID: PMC4145569.
Copy Download .nbib Format: NLM
Results from France's 2018 Report Card on Physical Activity for Children and Youth.

Journal of physical activity & health

Aubert S, Aucouturier J, Ganière C, Fillon A, Genin P, Schipman J, Larras B, Praznoczy C, Duclos M, Thivel D.
PMID: 30475139
J Phys Act Health. 2018 Nov 01;15:S360-S362. doi: 10.1123/jpah.2018-0511.

No abstract available.

Cite
Aubert S, Aucouturier J, Ganière C, et al. Results from France's 2018 Report Card on Physical Activity for Children and Youth. J Phys Act Health. 2018;15:S360-S362doi: 10.1123/jpah.2018-0511.
Aubert, S., Aucouturier, J., Ganière, C., Fillon, A., Genin, P., Schipman, J., Larras, B., Praznoczy, C., Duclos, M., & Thivel, D. (2018). Results from France's 2018 Report Card on Physical Activity for Children and Youth. Journal of physical activity & health, 15S360-S362. https://doi.org/10.1123/jpah.2018-0511
Aubert, Salomé, et al. "Results from France's 2018 Report Card on Physical Activity for Children and Youth." Journal of physical activity & health vol. 15 (2018): S360-S362. doi: https://doi.org/10.1123/jpah.2018-0511
Aubert S, Aucouturier J, Ganière C, Fillon A, Genin P, Schipman J, Larras B, Praznoczy C, Duclos M, Thivel D. Results from France's 2018 Report Card on Physical Activity for Children and Youth. J Phys Act Health. 2018 Nov 01;15:S360-S362. doi: 10.1123/jpah.2018-0511. PMID: 30475139.
Copy Download .nbib Format: NLM
Management of intracranial tuberculous mass lesions: how long should we treat for?.

Wellcome open research

Marais S, Van Toorn R, Chow FC, Manesh A, Siddiqi OK, Figaji A, Schoeman JF, Meintjes G.
PMID: 32047859
Wellcome Open Res. 2020 Feb 26;4:158. doi: 10.12688/wellcomeopenres.15501.3. eCollection 2019.

Tuberculous intracranial mass lesions are common in settings with high tuberculosis (TB) incidence and HIV prevalence. The diagnosis of such lesions, which include tuberculoma and tuberculous abscesses, is often presumptive and based on radiological features, supportive evidence of TB...

Cite
Marais S, Van Toorn R, Chow FC, et al. Management of intracranial tuberculous mass lesions: how long should we treat for?. Wellcome Open Res. 2020;4:158doi: 10.12688/wellcomeopenres.15501.3.
Marais, S., Van Toorn, R., Chow, F. C., Manesh, A., Siddiqi, O. K., Figaji, A., Schoeman, J. F., Meintjes, G. (2019). Management of intracranial tuberculous mass lesions: how long should we treat for?. Wellcome open research, 4158. https://doi.org/10.12688/wellcomeopenres.15501.3
Marais, Suzaan, et al. "Management of intracranial tuberculous mass lesions: how long should we treat for?." Wellcome open research vol. 4 (2019): 158. doi: https://doi.org/10.12688/wellcomeopenres.15501.3
Marais S, Van Toorn R, Chow FC, Manesh A, Siddiqi OK, Figaji A, Schoeman JF, Meintjes G. Management of intracranial tuberculous mass lesions: how long should we treat for?. Wellcome Open Res. 2020 Feb 26;4:158. doi: 10.12688/wellcomeopenres.15501.3. eCollection 2019. PMID: 32047859; PMCID: PMC6996525.3.
Copy Download .nbib Format: NLM
Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country.

The Journal of thoracic and cardiovascular surgery

Scherman J, Manganyi R, Human P, Pennel T, Brooks A, Brink J, Zilla P.
PMID: 30107929
J Thorac Cardiovasc Surg. 2019 Mar;157(3):886-893. doi: 10.1016/j.jtcvs.2018.06.083. Epub 2018 Jul 20.

OBJECTIVE: Although the results of aortic valve replacement are well documented for industrialized countries, the outcome in patients with rheumatic aortic valve disease in low- to middle-income countries is less well explored. The aim of this study was to...

Cite
Scherman J, Manganyi R, Human P, et al. Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. J Thorac Cardiovasc Surg. 2018;157(3):886-893doi: 10.1016/j.jtcvs.2018.06.083.
Scherman, J., Manganyi, R., Human, P., Pennel, T., Brooks, A., Brink, J., & Zilla, P. (2019). Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. The Journal of thoracic and cardiovascular surgery, 157(3), 886-893. https://doi.org/10.1016/j.jtcvs.2018.06.083
Scherman, Jacques, et al. "Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country." The Journal of thoracic and cardiovascular surgery vol. 157,3 (2019): 886-893. doi: https://doi.org/10.1016/j.jtcvs.2018.06.083
Scherman J, Manganyi R, Human P, Pennel T, Brooks A, Brink J, Zilla P. Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. J Thorac Cardiovasc Surg. 2019 Mar;157(3):886-893. doi: 10.1016/j.jtcvs.2018.06.083. Epub 2018 Jul 20. PMID: 30107929.
Copy Download .nbib Format: NLM
Editorial: Plant Genome Editing - Policies and Governance.

Frontiers in plant science

Schiemann J, Robienski J, Schleissing S, Spök A, Sprink T, Wilhelm RA.
PMID: 32218798
Front Plant Sci. 2020 Mar 11;11:284. doi: 10.3389/fpls.2020.00284. eCollection 2020.

No abstract available.

Cite
Schiemann J, Robienski J, Schleissing S, et al. Editorial: Plant Genome Editing - Policies and Governance. Front Plant Sci. 2020;11:284doi: 10.3389/fpls.2020.00284.
Schiemann, J., Robienski, J., Schleissing, S., Spök, A., Sprink, T., & Wilhelm, R. A. (2020). Editorial: Plant Genome Editing - Policies and Governance. Frontiers in plant science, 11284. https://doi.org/10.3389/fpls.2020.00284
Schiemann, Joachim, et al. "Editorial: Plant Genome Editing - Policies and Governance." Frontiers in plant science vol. 11 (2020): 284. doi: https://doi.org/10.3389/fpls.2020.00284
Schiemann J, Robienski J, Schleissing S, Spök A, Sprink T, Wilhelm RA. Editorial: Plant Genome Editing - Policies and Governance. Front Plant Sci. 2020 Mar 11;11:284. doi: 10.3389/fpls.2020.00284. eCollection 2020. PMID: 32218798; PMCID: PMC7078341.
Copy Download .nbib Format: NLM
A Mini-epidemic of Suspected Contact Dermatitis to Delta Airlines Uniforms.

Dermatitis : contact, atopic, occupational, drug

Schlarbaum JP, Dunnick CA, Scheman AJ, Powell DL, deShazo RA, Neeley AB, Warshaw EM, McKinney ZJ, Hylwa SA.
PMID: 33273238
Dermatitis. 2021 Jul-Aug 01;32(4):e69-e71. doi: 10.1097/DER.0000000000000692.

No abstract available.

Cite
Schlarbaum JP, Dunnick CA, Scheman AJ, et al. A Mini-epidemic of Suspected Contact Dermatitis to Delta Airlines Uniforms. Dermatitis. 2021;32(4):e69-e71doi: 10.1097/DER.0000000000000692.
Schlarbaum, J. P., Dunnick, C. A., Scheman, A. J., Powell, D. L., deShazo, R. A., Neeley, A. B., Warshaw, E. M., McKinney, Z. J., & Hylwa, S. A. (2021). A Mini-epidemic of Suspected Contact Dermatitis to Delta Airlines Uniforms. Dermatitis : contact, atopic, occupational, drug, 32(4), e69-e71. https://doi.org/10.1097/DER.0000000000000692
Schlarbaum, Jamie P, et al. "A Mini-epidemic of Suspected Contact Dermatitis to Delta Airlines Uniforms." Dermatitis : contact, atopic, occupational, drug vol. 32,4 (2021): e69-e71. doi: https://doi.org/10.1097/DER.0000000000000692
Schlarbaum JP, Dunnick CA, Scheman AJ, Powell DL, deShazo RA, Neeley AB, Warshaw EM, McKinney ZJ, Hylwa SA. A Mini-epidemic of Suspected Contact Dermatitis to Delta Airlines Uniforms. Dermatitis. 2021 Jul-Aug 01;32(4):e69-e71. doi: 10.1097/DER.0000000000000692. PMID: 33273238.
Copy Download .nbib Format: NLM
Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program.

Journal of thoracic disease

Ahmadi N, Mbuagbaw L, Hanna WC, Finley C, Agzarian J, Wen CK, Coret M, Schieman C, Shargall Y.
PMID: 32274084
J Thorac Dis. 2020 Mar;12(3):191-198. doi: 10.21037/jtd.2020.02.07.

BACKGROUND: Esophageal cancer is associated with poor prognosis. Diagnosis is often delayed, resulting in presentation with advanced disease. We developed a clinical score to predict the risk of a malignant diagnosis in symptomatic patients prior to any diagnostic tests.METHODS:...

Cite
Ahmadi N, Mbuagbaw L, Hanna WC, et al. Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program. J Thorac Dis. 2020;12(3):191-198doi: 10.21037/jtd.2020.02.07.
Ahmadi, N., Mbuagbaw, L., Hanna, W. C., Finley, C., Agzarian, J., Wen, C. K., Coret, M., Schieman, C., & Shargall, Y. (2020). Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program. Journal of thoracic disease, 12(3), 191-198. https://doi.org/10.21037/jtd.2020.02.07
Ahmadi, Negar, et al. "Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program." Journal of thoracic disease vol. 12,3 (2020): 191-198. doi: https://doi.org/10.21037/jtd.2020.02.07
Ahmadi N, Mbuagbaw L, Hanna WC, Finley C, Agzarian J, Wen CK, Coret M, Schieman C, Shargall Y. Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program. J Thorac Dis. 2020 Mar;12(3):191-198. doi: 10.21037/jtd.2020.02.07. PMID: 32274084; PMCID: PMC7139012.
Copy Download .nbib Format: NLM
Robust Exponential Decreasing Index (REDI): adaptive and robust method for computing cumulated workload.

BMJ open sport & exercise medicine

Moussa I, Leroy A, Sauliere G, Schipman J, Toussaint JF, Sedeaud A.
PMID: 31798948
BMJ Open Sport Exerc Med. 2019 Oct 30;5(1):e000573. doi: 10.1136/bmjsem-2019-000573. eCollection 2019.

OBJECTIVE: The purpose of this study was to define a new index the Robust Exponential Decreasing Index (REDI), which is capable of an improved analysis of the cumulative workload. This allows for precise control of the decreasing influence of...

Cite
Moussa I, Leroy A, Sauliere G, et al. Robust Exponential Decreasing Index (REDI): adaptive and robust method for computing cumulated workload. BMJ Open Sport Exerc Med. 2019;5(1):e000573doi: 10.1136/bmjsem-2019-000573.
Moussa, I., Leroy, A., Sauliere, G., Schipman, J., Toussaint, J. F., & Sedeaud, A. (2019). Robust Exponential Decreasing Index (REDI): adaptive and robust method for computing cumulated workload. BMJ open sport & exercise medicine, 5(1), e000573. https://doi.org/10.1136/bmjsem-2019-000573
Moussa, Issa, et al. "Robust Exponential Decreasing Index (REDI): adaptive and robust method for computing cumulated workload." BMJ open sport & exercise medicine vol. 5,1 (2019): e000573. doi: https://doi.org/10.1136/bmjsem-2019-000573
Moussa I, Leroy A, Sauliere G, Schipman J, Toussaint JF, Sedeaud A. Robust Exponential Decreasing Index (REDI): adaptive and robust method for computing cumulated workload. BMJ Open Sport Exerc Med. 2019 Oct 30;5(1):e000573. doi: 10.1136/bmjsem-2019-000573. eCollection 2019. PMID: 31798948; PMCID: PMC6863659.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries